Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $48.00 (+22%) * Over Last 12-Mos
Rating Score: 1.8 / 10   Percentile Rank: 13%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
10/20/2015 Credit Suisse Upgrade Neutral
(Underperform)
N/A
(N/A)
41.74 39.34 -5.75% Details
10/12/2015 JPMorgan Upgrade Neutral
(Underweight)
N/A
(N/A)
40.22 39.34 -2.19% Details
Like GSK Ratings? Also take a look at PFE, THRX, AGEN, NVS

GSK Ratings News